| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |